Medifast, Inc.  

(Public, NYSE:MED)   Watch this stock  
27.48
-0.04 (-0.15%)
Aug 2 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 26.68 - 27.93
52 week 12.97 - 28.58
Open 27.23
Vol / Avg. 269,533.00/216,381.00
Mkt cap 426.65M
P/E 29.27
Div/yield     -
EPS 0.94
Shares 15.53M
Beta 1.88
Inst. own 72%
Jul 26, 2012
Q2 2012 Medifast Inc Earnings Conference Call
May 8, 2012
Q1 2012 Medifast Inc Earnings Conference Call
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '12) 2011
Net profit margin 3.01% 6.22%
Operating margin 4.91% 9.18%
EBITD margin - 11.69%
Return on average assets 9.47% 18.57%
Return on average equity 14.33% 25.51%
Employees 860 -
Carbon Disclosure Rating - -

Address

11445 Cronhill Drive
OWINGS MILLS, MD 21117
United States - Map
+1-410-5818042 (Phone)
+1-410-5818070 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Medifast, Inc. (Medifast) is engaged in the production, distribution, and sale of weight management and disease management products and other consumable health and diet products. Medifast�s product lines include weight and disease management, meal replacement, and vitamins. The Company�s operations are primarily conducted through five of its wholly owned subsidiaries: Jason Pharmaceuticals, Inc. (Jason), Take Shape for Life, Inc. (TSFL), Jason Enterprises, Inc., Jason Properties, LLC and Seven Crondall, LLC. The Company expanded the Medifast product line during the year ended December 31, 2011, by introducing several new products. The products introduced included the Medifast Spiced Pancake, an addition to the Pancake line, including Original and Chocolate Chip varieties. It offers a variety of weight and disease management products under the Medifast and Essential brands and for select private label customer. During 2011, the Company opened 31 new Medifast Weight Control Centers.

Officers and directors

Michael C. MacDonald Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation - Reuters
Margaret MacDonald Sheetz President, Chief Operating Officer, Director
Age: 35
Bio & Compensation - Reuters
Brendan N. Connors CPA Chief Financial Officer
Age: 34
Bio & Compensation - Reuters
Jason L. Groves Esq. Executive Vice President, General Counsel, Director
Age: 41
Bio & Compensation - Reuters
Harvey C. Barnum Jr. Independent Director
Age: 72
Bio & Compensation - Reuters
Barry B. Bondroff CPA Independent Director
Age: 64
Bio & Compensation - Reuters
Charles P. Connolly Independent Director
Age: 63
Bio & Compensation - Reuters
George J. Lavin Jr., Esq. Independent Director
Age: 83
Bio & Compensation - Reuters
Catherine T. Maguire Independent Director
Age: 62
Bio & Compensation - Reuters